- Home
- REXR vs SNN Comparison
REXR vs SNN Comparison
Compare REXR & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REXR
- SNN
- Stock Information
- Founded
- REXR 2013
- SNN 1856
- Country
- REXR United States
- SNN United Kingdom
- Employees
- REXR N/A
- SNN N/A
- Industry
- REXR Real Estate Investment Trusts
- SNN Industrial Specialties
- Sector
- REXR Real Estate
- SNN Health Care
- Exchange
- REXR Nasdaq
- SNN Nasdaq
- Market Cap
- REXR 8.6B
- SNN 13.2B
- IPO Year
- REXR 2013
- SNN 1999
- Fundamental
- Price
- REXR $42.27
- SNN $37.32
- Analyst Decision
- REXR Hold
- SNN Hold
- Analyst Count
- REXR 9
- SNN 3
- Target Price
- REXR $40.78
- SNN $31.50
- AVG Volume (30 Days)
- REXR 2.7M
- SNN 649.0K
- Earning Date
- REXR 10-15-2025
- SNN 10-30-2025
- Dividend Yield
- REXR 4.07%
- SNN 1.95%
- EPS Growth
- REXR 11.21
- SNN 59.91
- EPS
- REXR 1.35
- SNN 0.56
- Revenue
- REXR $986,532,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- REXR $9.35
- SNN $7.75
- Revenue Next Year
- REXR $6.25
- SNN $5.37
- P/E Ratio
- REXR $31.39
- SNN $33.03
- Revenue Growth
- REXR 13.72
- SNN 5.35
- 52 Week Low
- REXR $29.68
- SNN $23.69
- 52 Week High
- REXR $52.37
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- REXR 59.89
- SNN 55.51
- Support Level
- REXR $42.50
- SNN $37.10
- Resistance Level
- REXR $43.79
- SNN $38.59
- Average True Range (ATR)
- REXR 0.83
- SNN 0.41
- MACD
- REXR -0.06
- SNN -0.27
- Stochastic Oscillator
- REXR 59.25
- SNN 34.96
About REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.